TY - JOUR
T1 - Arteriovenous Fistula Placement, Maturation, and Patency Loss in Older Patients Initiating Hemodialysis
AU - Qian, Joyce Z.
AU - McAdams-DeMarco, Mara
AU - Ng, Derek K.
AU - Lau, Bryan
N1 - Publisher Copyright:
© 2020 National Kidney Foundation, Inc.
PY - 2020/10
Y1 - 2020/10
N2 - Rationale & Objective: The current clinical guidelines for vascular access do not have specific recommendations for older hemodialysis patients. Our study aimed to determine the association of age with arteriovenous fistula (AVF) placement, maturation, and primary and secondary patency loss among older hemodialysis recipients. Study Design: Retrospective cohort study. Setting & Participants: A US national cohort of incident hemodialysis patients 67 years or older (N = 43,851) assembled from the US Renal Data System. Exposure: Age at dialysis initiation. Outcomes: AVF placement, maturation, primary patency loss, and abandonment. Analytical Approach: Cause-specific and subdistribution proportional hazards models were used to examine the association of age and AVF outcomes, with kidney transplantation, peritoneal dialysis, and death treated as competing events. Age cutoff was identified by restricted cubic splines. We compared crude and inverse probability–weighted cumulative incidence functions using Gray's test. Results: As compared with those aged 67-<77 years, patients 77 years or older had significantly lower probabilities of AVF placement (adjusted cause-specific HR [cHR], 0.96 [95% CI, 0.92-0.99]; adjusted subdistribution HR [sHR], 0.92 [95% CI, 0.89-0.95]; Gray's test P < 0.001) and maturation (adjusted cHR, 0.95 [95% CI, 0.91-0.99]; adjusted sHR, 0.93 [95% CI, 0.90-0.97]; P < 0.001). However, age was not associated with AVF primary (adjusted cHR, 1.05 [95% CI, 1.00-1.11]; adjusted sHR, 1.04 [95% CI, 0.99-1.09]; P = 0.09) or secondary (adjusted cHR, 1.06 [95% CI, 0.94-1.20]; adjusted sHR, 1.05 [95% CI, 0.93-1.18]; P = 0.4) patency loss. Limitations: Reliance on administrative claims to ascertain AVF outcomes. Conclusions: The likelihood of AVF maturation is an important consideration for vascular access planning.
AB - Rationale & Objective: The current clinical guidelines for vascular access do not have specific recommendations for older hemodialysis patients. Our study aimed to determine the association of age with arteriovenous fistula (AVF) placement, maturation, and primary and secondary patency loss among older hemodialysis recipients. Study Design: Retrospective cohort study. Setting & Participants: A US national cohort of incident hemodialysis patients 67 years or older (N = 43,851) assembled from the US Renal Data System. Exposure: Age at dialysis initiation. Outcomes: AVF placement, maturation, primary patency loss, and abandonment. Analytical Approach: Cause-specific and subdistribution proportional hazards models were used to examine the association of age and AVF outcomes, with kidney transplantation, peritoneal dialysis, and death treated as competing events. Age cutoff was identified by restricted cubic splines. We compared crude and inverse probability–weighted cumulative incidence functions using Gray's test. Results: As compared with those aged 67-<77 years, patients 77 years or older had significantly lower probabilities of AVF placement (adjusted cause-specific HR [cHR], 0.96 [95% CI, 0.92-0.99]; adjusted subdistribution HR [sHR], 0.92 [95% CI, 0.89-0.95]; Gray's test P < 0.001) and maturation (adjusted cHR, 0.95 [95% CI, 0.91-0.99]; adjusted sHR, 0.93 [95% CI, 0.90-0.97]; P < 0.001). However, age was not associated with AVF primary (adjusted cHR, 1.05 [95% CI, 1.00-1.11]; adjusted sHR, 1.04 [95% CI, 0.99-1.09]; P = 0.09) or secondary (adjusted cHR, 1.06 [95% CI, 0.94-1.20]; adjusted sHR, 1.05 [95% CI, 0.93-1.18]; P = 0.4) patency loss. Limitations: Reliance on administrative claims to ascertain AVF outcomes. Conclusions: The likelihood of AVF maturation is an important consideration for vascular access planning.
KW - AVF outcome
KW - Hemodialysis
KW - age
KW - arteriovenous fistula (AVF)
KW - competing risks
KW - elderly
KW - end-stage renal disease (ESRD)
KW - individualized treatment plan
KW - maturation
KW - older adults
KW - patency
KW - placement
KW - survival analysis
KW - vascular access
UR - http://www.scopus.com/inward/record.url?scp=85087709243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087709243&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2020.02.449
DO - 10.1053/j.ajkd.2020.02.449
M3 - Article
C2 - 32654891
AN - SCOPUS:85087709243
SN - 0272-6386
VL - 76
SP - 480-489.e1
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -